Education
| Institution | Degree | Dept or School | End Date |
|---|---|---|---|
| Dana-Farber Cancer Institute | Post-Doctoral Fellowship, Oncology | 05/2014 | |
| Brigham and Women's Hospital | Fellowship, Cardiology | 06/2007 | |
| Johns Hopkins Hospital | Residency, Internal Medicine | 06/2004 | |
| University of Connecticut | MD | Medicine | 06/2001 |
| Johns Hopkins University | BA | Biology | 06/1996 |
Awards & Honors
| Award | Conferred By | Date |
|---|---|---|
| Elected Member | Association of American Physicians (AAP) | 2024 |
| Inaugural Holder of the William Grossman Distinguished Professorship in Cardiology | UCSF | 2021 |
| Elected Member | American Society of Clinical Investigation (ASCI) | 2020 |
| Alumni Achievement Award | Stanley J. Sarnoff Cardiovascular Research Foundation | 2016 |
| Biomedical Science Impact Award | Vanderbilt University | 2016 |
| Thomas Smith Award in Heart Failure Research | Brigham and Women's Hospital, Harvard Medical School | 2009 |
Clinical Trials
- 64Cu-GRIP B in Patients With Acute Myocarditis (NCT07481136)Related Conditions: Myocarditis| Start Date: | End Date:
Grants and Funding
- Long-Term Cardiovascular Sequelae of Cancer Immunotherapies | NIH | 2021-05-01 - 2026-04-30 | Role: Principal Investigator
- Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis | NIH | 2021-05-01 - 2026-04-30 | Role: Principal Investigator
- Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension | NIH | 2019-08-01 - 2024-05-31 | Role: Principal Investigator
- Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension | NIH | 2018-09-15 - 2019-08-31 | Role: Principal Investigator
- A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy | NIH | 2009-09-30 - 2014-06-30 | Role: Principal Investigator
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
- T cells in acute and chronic myocarditis: from diagnosis to treatment.| |
PubMed
- Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy.| |
PubMed
- Multimodality Imaging in Myocarditis: Integrating Etiology, Diagnosis, and Risk Stratification.| |
PubMed
- A retrospective pharmacovigilance analysis based on the FAERS database reveals sex-associated differences in toxicities of CAR T-cell therapy.| |
PubMed
- Targeting JAK/STAT With Ruxolitinib in Acute Fulminant Myocarditis.| |
PubMed
- Innate and Adaptive Immune Mechanisms in Pericarditis: Pathobiology and Clinical Implications.| |
PubMed
- PD-L1 in ICI Myocarditis: When the Immune Brake Fails.| |
PubMed
- Cardiac Biomarkers in Patients With Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors.| |
PubMed
- Immune checkpoint inhibitor-associated myocarditis: a novel risk score.| |
PubMed
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.| |
PubMed